Alto Neuroscience, Inc. Common Stock (ANRO)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
ANRO Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
ANRO Quarterly Cost of Revenue ($97.00K → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
ANRO cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 184,000 | |
| 0 | |
| 0 | |
| 100,000 | |
| 0 | |
| 170,000 | |
| 0 | |
| 0 | |
| 97,000 | |
| 92,000 | |
| 0 | |
| 100,000 | |
| 86,000 | |
| 97,000 |